Skorpios Trust
CIK 1869333 · View on SEC EDGAR ↗
- Portfolio value
- $53.2M
- Positions
- 2
- As of
- Sept. 30, 2025 Data as of Q3 2025
Portfolio value QoQ: +43.4% 13F does not disclose cash
- Top 10 holdings weight
- 100.00%
- Top 25 holdings weight
- 100.00%
- Positions above 1%
- 1
- Effective number of positions
- 1.0
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q3 2025: 0.0% Est. buys $0 · sells $23,500,000
Median holding: 4.0 quarters Tracked Q4 2024–Q3 2025 · 100.0% still held
- New positions
- 0
- Increased
- 0
- Decreased
- 1
- Closed
- 0
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- Top moves The biggest position increases and decreases this quarter.
- Related The person behind this filer, where we can match one.
Performance vs S&P 500
Annualized: +174.3% · S&P 500: +18.3%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 100.0% · Options excluded: 0.0%
Sector breakdown
Full portfolio 2 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| STOK Stoke Therapeutics, Inc. - Common Stock | $53,020,254 | 99.68% | 2,256,181 | $16,062,600 | Down ×2 | ||
| XBI XBI | $168,937 | 0.32% | 1,686 | $29,117 | |||
| No matches | |||||||
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| STOK | Trimmed | -1.0M | +$16.1M |
| XBI | Price move only | +0 | +$29K |